Small EJ - Search Results

1

Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy.

Halabi S, Lin CY, Small EJ, Armstrong AJ, Kaplan EB, Petrylak D, Sternberg CN, Shen L, Oudard S, de Bono J, Sartor O. Halabi S, et al. Among authors: small ej. J Natl Cancer Inst. 2013 Nov 20;105(22):1729-37. doi: 10.1093/jnci/djt280. Epub 2013 Oct 17. J Natl Cancer Inst. 2013. PMID: 24136890 Free PMC article. Clinical Trial.

2

Prostate cancer: who to screen, and what the results mean.

Small EJ. Small EJ. Geriatrics. 1993 Dec;48(12):28-30, 35-8. Geriatrics. 1993. PMID: 7504646 Review.

3

A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma.

Small EJ, Frye JW, Wilkinson MJ, Carroll PR, Ernest ML, Stagg RJ. Small EJ, et al. Cancer. 1994 Jun 1;73(11):2803-7. doi: 10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6. Cancer. 1994. PMID: 8194022 Clinical Trial.

4

Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease.

Small EJ, Venook AP, Damon LE. Small EJ, et al. Cancer. 1993 Aug 1;72(3):905-8. doi: 10.1002/1097-0142(19930801)72:3<905::aid-cncr2820720340>3.0.co;2-2. Cancer. 1993. PMID: 8334644 Review.

5

The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer.

Small EJ, Srinivas S. Small EJ, et al. Cancer. 1995 Oct 15;76(8):1428-34. doi: 10.1002/1097-0142(19951015)76:8<1428::aid-cncr2820760820>3.0.co;2-t. Cancer. 1995. PMID: 8620419

6

A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium.

Small EJ, Fippin LJ, Ernest ML, Carroll PR. Small EJ, et al. Cancer. 1996 Oct 15;78(8):1775-80. doi: 10.1002/(sici)1097-0142(19961015)78:8<1775::aid-cncr18>3.0.co;2-v. Cancer. 1996. PMID: 8859191 Clinical Trial.

7

Prostate cancer.

Small EJ. Small EJ. Curr Opin Oncol. 1997 May;9(3):277-86. doi: 10.1097/00001622-199709030-00011. Curr Opin Oncol. 1997. PMID: 9229151 Review.

8

Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma.

Small EJ, Baron A, Bok R. Small EJ, et al. Cancer. 1997 Nov 1;80(9):1755-9. doi: 10.1002/(sici)1097-0142(19971101)80:9<1755::aid-cncr9>3.0.co;2-d. Cancer. 1997. PMID: 9351544 Clinical Trial.

9

Prostate cancer, Incidence, management and outcomes.

Small EJ. Small EJ. Drugs Aging. 1998 Jul;13(1):71-81. doi: 10.2165/00002512-199813010-00007. Drugs Aging. 1998. PMID: 9679210 Review.

10

Pyrazoloacridine for the treatment of hormone-refractory prostate cancer.

Small EJ, Fippin LJ, Whisenant SP. Small EJ, et al. Cancer Invest. 1998;16(7):456-61. doi: 10.3109/07357909809011699. Cancer Invest. 1998. PMID: 9774952 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

477 results

Search Page

Filters